2007: Biologic Therapies and RA Comorbidity

Biologic Therapies and RA Comorbidity

1339

Combination TNF-Inhibitor-Methotrexate Therapy is Superior yo Methotrexate Monotherapy in Reducing the Risk of Acute Myocardial Infarction in Patients with Rheumatoid Arthritis

1340

The Effect of Rheumatic Disease Treatment on the Risk of Myocardial Infarction: Increased Risk from Rofecoxib, Valdecoxib and Celecoxib; Decreased Risk from Anti-TNF Therapy

1341

HLA-DRB1 Shared Epitope Alleles are Independently Associated with the Severity of Coronary Calcification in Rheumatoid Arthritis

1342

TNF-α Antagonists and Heart Failure Hospitalization in Elderly Patients with Rheumatoid Arthritis

1343

Rheumatoid Arthritis, Interstitial Lung Disease, Mortality and Anti-TNF Therapy: Results from the BSR Biologics Register (BSRBR)

1344

Are Cancers Occurring in RA Patients Treated with TNF-Antagonists Particularly Aggressive?

See more of: ACR Abstract Submission ACR Concurrent Abstract Session

<< Previous Session Level | Next Session Level >>